MyAverix Finance
TWO · Healthcare
Orient Europharma Co Ltd (4120)
Drug Manufacturers - Specialty & Generic
Orient Europharma Co Ltd (4120) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4120
Orient Europharma Co Ltd (4120) — FAQ
What is 4120's P/E ratio?
The price-to-earnings (P/E) ratio for Orient Europharma Co Ltd (4120) is 18.00 (data as of 2026-05-23).
Does Orient Europharma Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Orient Europharma Co Ltd (4120). Check the MyAverix Finance app for the latest dividend data.
What sector is Orient Europharma Co Ltd in?
Orient Europharma Co Ltd (4120) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 4120 listed on?
4120 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.